EA
TPST icon

Emerald Advisers’s Tempest Therapeutics TPST Stock Holding History

Emerald Advisers’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4
Closed -$109K – 333
2015
Q4 		$109K Sell
4
-104
-96% -$3.43M 0.01% 314
2015
Q3 		$2.67M Buy
+108
New +$7.27M 0.14% 175
2015
Q1 		– Sell
-28
Closed -$3.57M – 359
2014
Q4 		$3.57M Sell
28
-56
-67% -$4.1M 0.19% 145
2014
Q3 		$4.07M Buy
84
+1
+1% +$35.1K 0.24% 136
2014
Q2 		$2.22M Buy
83
+43
+108% +$1.01M 0.13% 194
2014
Q1 		$1.03M Buy
+40
New +$1.13M 0.06% 249

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Emerald Advisers's TPST Position: Q1 2016 in Review

Emerald Advisers sold out of Tempest Therapeutics (TPST) in Q1 2016, closing a stake of 4 shares — an estimated $109K sold.

Emerald Advisers first reported a position in TPST in Q1 2014 and held it in 6 quarters. The position peaked at $4.07M in Q3 2014. 73 funds tracked by Wall St. Rank hold TPST as of Q1 2016.

  • Emerald Advisers reported no remaining Tempest Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Emerald Advisers sold 4 Tempest Therapeutics shares in Q1 2016, an estimated $109K.
  • Emerald Advisers first reported a position in Tempest Therapeutics in Q1 2014 and held it in 6 quarters.
  • Emerald Advisers's Tempest Therapeutics position peaked at $4.07M in Q3 2014.
  • 73 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2016.

Based on Emerald Advisers's 13F filing for Q1 2016, filed 28 Apr 2016.